
About this event
This talk is in-person only; registration is required
EVENT POSTPONED - to be RESCHEDULED SOON
please check here or sign up for our announcements at the bottom of this page
SPEAKER BIO: Diane Hendel, NP-C, MSN, MBA is a board certified nurse practitioner with a primary care practice, Arlington Eldercare LLC, specializing in chronic illness, palliative care, and advanced dementia. She collaborates with mental health therapists to provide personalized ketamine assisted psychotherapy. Ketamine assisted therapy for palliative care and end of life distress.
Experienced in undergraduate education, program development, case management, and corporate health promotion.
Ketamine Training Center, Ketamine Assisted Psychotherapy, Certificate, 2022. Member, Ketamine Psychotherapy Associates
University of California Berkeley Center for the Science of Psychedelics, Psychedelic Facilitation Post-Master’s Certificate, in progress
Participant in clinical trial at Johns Hopkins University, 2015, studying brain function of long term meditators administered psilocybin.
RELATED LINKS:
- Nothing seemed to treat their depression. Then they tried ketamine.
https://wapo.st/3S84MKq - Who should try ketamine therapy? What does it feel like?
https://wapo.st/3drr5f8 - Clinical Effectiveness of Intravenous Racemic Ketamine Infusions in a Large Community Sample of Patients With Treatment-Resistant Depression, Suicidal Ideation, and Generalized Anxiety Symptoms: A Retrospective Chart Review
https://www.psychiatrist.com/jcp/depression/clinical-effectiveness-intravenous-racemic-ketamine-treatment-resistant-depression-suicidal-ideation-generalized-anxiety-symptoms/ - A review of potential neuropathological changes associated with ketamine
https://doi.org/10.1080/14740338.2022.2071867 - At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial
https://www.sciencedirect.com/science/article/pii/S016503272200762 - Neurobiology of the Rapid-Acting Antidepressant Effects of Ketamine: Impact and Opportunities
https://doi.org/10.1016/j.biopsych.2020.12.006